Kyoto University’s Center for iPS Cell Research and Application (CiRA) purchased Fluidigm’s BioMark™ System to use in researching stem cell reprogramming.
CiRA is using the microfluidic properties of BioMark’s integrated fluidic circuits to analyze selected genes in induced pluripotent stem (iPS) cells. The institute is also using the system to quantify copies of specific genes transferred into a cell to generate iPS cells.
